C2E2 is an orally bioavailable, self-administered, water mixable powder which, when swallowed, enters the bloodstream and binds to radioactive and nonradioactive metals such as plutonium, americium, lead, and gadolinium which are then excreted via the kidneys allowing for rapid corporal removal to prevent tissue deposition and long term damage.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Proven Manufacturability
Technology Readiness Level: TRL 6
Organization Type: Corporation
Market Keywords: prescription, countermeasure, orally bioavailable